HFA Premium Access

Beta-blockers uptitration between infusions predicts event-free survival in advanced heart failure treated with repeated cures of low-dose levosimendan

Congress Presentation

About the speaker

Doctor Patrick Yerly

University Hospital Centre Vaudois (CHUV), Lausanne (Switzerland)
0 follower

7 more presentations in this session

Influence of a continuous veno-venous hemofiltration on the long-term prognosis in patients with an advanced heart failure and an acute coronary syndrome

Speaker: Doctor O. Trebacz (Krakow, PL)


Utility of cTnT-hs and sAXL for prognosis evaluation after heart transplantation

Speaker: Doctor S. Mirabet Perez (Barcelona, ES)


Predictors of mortality at six months after in advanced heart failure patients attended in primary care

Speaker: Doctor J. Verdu (Barcelona, ES)


Low dose of basiliximab for induction immunosuppresion therapy for heart transplant results in favourable outcomes

Speaker: Doctor V. kittipibul (Durham, US)


Intermitent treatment with levosimendan in outpatients with chronic advanced heart failure: our experience.

Speaker: Doctor J. Garcia Pinilla (Malaga, ES)


Access the full session

Poster Session 1 - Advanced heart failure

Speakers: Doctor P. Yerly, Doctor O. Trebacz, Doctor S. Mirabet Perez, Doctor J. Verdu, Doctor V. kittipibul...

About the event


Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb